A broadly-neutralizing antibody against <i>Ebolavirus</i> glycoprotein that potentiates the breadth and neutralization potency of other antibodiesFrancesca R. Donnellan(University of Oxford), Simon J. Draper(University of Oxford)bioRxiv (Cold Spring Harbor Laboratory)June 25, 202410.1101/2024.06.21.600001Cited by 0SaveCiteExport RISWatch citationsRelated PapersSafety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children|The Lancet Infectious Diseases|2024|39Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled phase 2b trial in children|medRxiv|2024|1